ELAN (STOCKS)
Elanco Animal Health Incorporated Common Stock
$25.987700
+0.377700 (+1.47%)
Prev close: $25.610000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jeffrey N. Simmons
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12,982.20M
- Employees
- 9,450
- P/E (TTM)
- 351.30
- P/B (TTM)
- 1.89
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $4.59B |
| Benefits Costs and Expenses | $4.61B |
| Cost Of Revenue | $2.07B |
| Costs And Expenses | $4.61B |
| Gross Profit | $2.52B |
| Operating Expenses | $2.54B |
| Selling, General, and Administrative Expenses | $1.39B |
| Research and Development | $356.00M |
| Other Operating Expenses | $791.00M |
| Operating Income/Loss | -$16.00M |
| Income/Loss From Continuing Operations After Tax | $36.00M |
| Income/Loss From Continuing Operations Before Tax | -$16.00M |
| Income Tax Expense/Benefit | -$52.00M |
| Net Income/Loss | $36.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $36.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $36.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.07 |
| Diluted Earnings Per Share | $0.06 |
| Basic Average Shares | 1,488,600,000 |
| Diluted Average Shares | 1,496,400,000 |
| Assets | $13.55B |
| Current Assets | $3.49B |
| Inventory | $1.71B |
| Other Current Assets | $1.79B |
| Noncurrent Assets | $10.06B |
| Fixed Assets | $1.39B |
| Intangible Assets | $3.60B |
| Other Non-current Assets | $5.07B |
| Liabilities | $6.80B |
| Current Liabilities | $1.46B |
| Accounts Payable | $352.00M |
| Other Current Liabilities | $1.10B |
| Noncurrent Liabilities | $5.35B |
| Long-term Debt | $3.77B |
| Other Non-current Liabilities | $1.58B |
| Equity | $6.75B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.75B |
| Liabilities And Equity | $13.55B |
| Net Cash Flow From Operating Activities | $629.00M |
| Net Cash Flow From Operating Activities, Continuing | $629.00M |
| Net Cash Flow From Investing Activities | -$305.00M |
| Net Cash Flow From Investing Activities, Continuing | -$305.00M |
| Net Cash Flow From Financing Activities | -$289.00M |
| Net Cash Flow From Financing Activities, Continuing | -$289.00M |
| Exchange Gains/Losses | -$20.00M |
| Net Cash Flow | $15.00M |
| Net Cash Flow, Continuing | $35.00M |
| Comprehensive Income/Loss | -$403.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $176.00M |
| Other Comprehensive Income/Loss | -$481.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $140.00M |